Jonathan W. Friedberg
Abstract
"Bendamustine in chronic lymphocytic leukemia: the future is combination therapy." Leukemia & Lymphoma, 50(9), pp. 1399–1400
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
"Bendamustine in chronic lymphocytic leukemia: the future is combination therapy." Leukemia & Lymphoma, 50(9), pp. 1399–1400
Key concepts: Bendamustine, Chronic lymphocytic leukemia, Medicine, Leukemia, Oncology, Venetoclax, Internal medicine, Immunology